@prefix this: <http://purl.org/np/RAOE99VP_HbvtZOrGDBDGP2izlwpCwpqohyOcubyj2CYI> .
@prefix sub: <http://purl.org/np/RAOE99VP_HbvtZOrGDBDGP2izlwpCwpqohyOcubyj2CYI#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://identifiers.org/pubchem.compound/441300> a biolink:ChemicalEntity;
    rdfs:label "Abacavir";
    biolink:category biolink:ChemicalEntity .
  
  <http://identifiers.org/pubchem.compound/54726191> a biolink:ChemicalEntity;
    rdfs:label "dolutegravir";
    biolink:category biolink:ChemicalEntity .
  
  <http://identifiers.org/pubchem.compound/60825> a biolink:ChemicalEntity;
    rdfs:label "lamivudine";
    biolink:category biolink:ChemicalEntity .
  
  <http://purl.obolibrary.org/obo/MONDO_0005109> a biolink:DiseaseOrPhenotypicFeature;
    rdfs:label "HIV-1 infection";
    biolink:category biolink:DiseaseOrPhenotypicFeature .
  
  sub:_1 rdf:object <http://identifiers.org/pubchem.compound/54726191>;
    rdf:predicate biolink:treated_by;
    rdf:subject <http://purl.obolibrary.org/obo/MONDO_0005109>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25c0c6d5-f7b0-48e4-e054-00144ff8d46c> .
  
  sub:_2 rdf:object <http://purl.obolibrary.org/obo/MONDO_0005109>;
    rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/441300>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25c0c6d5-f7b0-48e4-e054-00144ff8d46c> .
  
  sub:_3 rdf:object <http://identifiers.org/pubchem.compound/60825>;
    rdf:predicate biolink:associated_with;
    rdf:subject <http://purl.obolibrary.org/obo/MONDO_0005109>;
    a biolink:Association;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25c0c6d5-f7b0-48e4-e054-00144ff8d46c> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2022-10-13T12:18:06.846456"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627;
    prov:wasQuotedFrom "Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection. It is available in a combination product alongside dolutegravir and lamivudine for the. treatment of adult and pediatric patients with HIV--1 who weigh. 10 kg who weigh ≥10 kg are considered to be patients with the disease. Adults and children who weigh more than 10 kg are recommended to take the drug." .
  
  biolink: pav:version "2.3.0" .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB";
    npx:hasSignature "ISOnYlaq1M4K1yYMcBV1OIbbSyEIG3sbEUxNg23HUJLn8AlNCyijCovMHy3TOKPzb8fdIbUhf6gI3SvHRhorIWG/2JAWzqnuzumlxI285BGaCXGeiiYzUVrlgmdchvOm2fBsP7XrbQ6ThZarDQI1chAGvMcAQ2G03O12pgIp0URpYUIvwJGxwjmwoki34Lz1rvsoby2vwnCtkMvjmss1VSS4b8G46GaVnAppkZimuK/mfAEkqm35T5BwiqIlm5LVd5caYpsIg1dqsefxo/hLx7z7yGLzaCOGuPfFSTGcO9d1tD2X1xvnoRl8IpzpjZDViSirUnWoexxhYh6SRTDQpw==";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2022-10-13T12:18:06.846456"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}